Opinion · 9 Jan 2024
EditorialPublished 30 Aug 2021
Explicit and Sensitive Biomarker in the Blood Predicts Symptomatic COVID-19 Infection
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Research article · 2021
Human DNA AI Model to Predict COVID-19 Symptomatic or Asymptomatic Percentages
Research article · 28 Aug 2020
Predicted Treatment for COVID-19 Infection: Design, Docking Study and ADMET Prediction of Novel Small Molecules as Serine Protease Inhibitors
Conference abstract · 23 Jun 2025
Analysis of biological biomarkers in COVID-19 and their role in severity and clinical progression
Conference abstract · 2024
Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joshua Ikoni Ogaji”

